HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.

AuthorsMarchina van der Ende, Jan Willem Mulder, Marcel van den Berge, Willem Blok, Martin Schutten
JournalAIDS (London, England) (AIDS) Vol. 21 Issue 12 Pg. 1661-2 (Jul 31 2007) ISSN: 0269-9370 [Print] England
PMID17630571 (Publication Type: Case Reports, Letter)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b
Topics
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Antiviral Agents (therapeutic use)
  • Female
  • HIV Infections (complications)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Male
  • Polyethylene Glycols
  • Recombinant Proteins
  • Sarcoma, Kaposi (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: